Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 8, 2007, Pages 3023-3025

  Nsobya, Samuel L ^a   Dokomajilar, Christian ^b   Joloba, Moses ^a   Dorsey, Grant ^b   Rosenthal, Philip J ^b,c  

^a MAKERERE UNIVERSITY   (Uganda)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ARTESUNATE;

ANTIBIOTIC RESISTANCE; ARTICLE; DNA POLYMORPHISM; HAPLOTYPE; MALARIA; MUTATION; NONHUMAN; PFCRT GENE; PFMDR1 GENE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; UGANDA;

ALLELES; AMODIAQUINE; ANIMALS; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; ETHANOLAMINES; FLUORENES; HUMANS; INFANT; MALARIA, FALCIPARUM; MEMBRANE TRANSPORT PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; MUTATION; PLASMODIUM FALCIPARUM; POLYMORPHISM, GENETIC; PROTOZOAN PROTEINS; SESQUITERPENES; TREATMENT OUTCOME; UGANDA;

EID: 34547626439     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00012-07     Document Type: Article

References (23)

1. Adjuik, M., P. Agnamey, A. Babiker, S. Borrmann, P. Brasseur, M. Cisse, F. Cobelens, S. Diallo, J. F. Faucher, P. Garner, S. Gikunda, P. G. Kremsner, S. Krishna, B. Lell, M. Loolpapit, P. B. Matsiegui, M. A. Missinou, J. Mwanza, F. Ntoumi, P. Olliaro, P. Osimbo, P. Rezbach, E. Some, and W. R. Taylor. 2002. Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial. Lancet 359:1365-1372.
2. Alifrangis, M., M. B. Dalgaard, J. P. Lusingu, L. S. Vestergaard, T. Staalsoe, A. T. Jensen, A. Enevold, A. M. Ronn, I. F. Khalil, D. C. Warhurst, M. M. Lemnge, T. G. Theander, and I. C. Bygbjerg. 2006. Occurrence of the Southeast Asian/South American SVMNT haplotype of the chloroquine-resistance transporter gene in Plasmodium falciparum in Tanzania. J. Infect. Dis. 193:1738-1741.
3. Bray, P. G., S. R. Hawley, M. Mungthin, and S. A. Ward. 1996. Physicochemical properties correlated with drug resistance and the reversal of drug resistance in Plasmodium falciparum. Mol. Pharmacol. 50:1559-1566.
4. Bukirwa, H., A. Yeka, M. R. Kamya, A. Talisuna, K. Banek, N. Bakyaita, J. B. Rwakimari, P. J. Rosenthal, F. Wabwire-Mangen, G. Dorsey, and S. G. Staedke. 2006. Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda. PLoS Clin. Trials 1:e7.
5. Cattamanchi, A., D. Kyabayinze, A. Hubbard, M. R. Kamya, P. J. Rosenthal, and G. Dorsey. 2003. Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of MSP-1, MSP-2, and GLURP. Am. J. Trop. Med. Hyg. 68:133-139.
6. Dokomajilar, C., Z. M. Lankoande, G. Dorsey, I. Zongo, J. B. Ouedraogo, and P. J. Rosenthal. 2006. Roles of specific Plasmodium falciparum mutations in resistance to amodiaquine and sulfadoxine-pyrimethamine in Burkina Faso. Am. J. Trop. Med. Hyg. 75:162-165.
7. Dokomajilar, C., S. L. Nsobya, B. Greenhouse, P. J. Rosenthal, and G. Dorsey. 2006. Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic. Antimicrob. Agents Chemother. 50:1893-1895.
8. Duraisingh, M. T., P. Jones, I. Sambou, L. von Seidlein, M. Pinder, and D. C. Warhurst. 2000. The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Mol. Biochem. Parasitol. 108:13-23.
9. Fidock, D. A., T. Nomura, A. K. Talley, R. A. Cooper, S. M. Dzekunov, M. T. Ferdig, L. M. Ursos, A. B. Sidhu, B. Naude, K. W. Deitsch, X. Z. Su, J. C. Wootton, P. D. Roepe, and T. E. Wellems. 2000. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol. Cell 6:861-871.
10. Greenwood, B. M., K. Bojang, C. J. Whitty, and T. A. Targett. 2005. Malaria. Lancet 365:1487-1498.
11. Holmgren, G., J. P. Gil, P. M. Ferreira, M. I. Veiga, C. O. Obonyo, and A. Bjorkman. 2006. Amodiaquine resistant Plasmodium falciparum malaria in vivo is associated with selection of pfcrt 76T and pfmdr1 86Y. Infect. Genet. Evol. 6:309-314.
12. Mutabingwa, T. K., D. Anthony, A. Heller, R. Hallett, J. Ahmed, C. Drakeley, B. M. Greenwood, and C. J. Whitty. 2005. Amodiaquine alone, amodiaquine+ sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. Lancet 365:1474- 1480.
13. Ochong, E. O., I. V. van den Broek, K. Keus, and A. Nzila. 2003. Short report: association between chloroquine and amodiaquine resistance and allelic variation in the Plasmodium falciparum multiple drug resistance 1 gene and the chloroquine resistance transporter gene in isolates from the upper Nile in southern Sudan. Am. J. Trop. Med. Hyg. 69:184-187.
14. Olliaro, P., C. Nevill, J. LeBras, P. Ringwald, P. Mussano, P. Garner, and P. Brasseur. 1996. Systematic review of amodiaquine treatment in uncomplicated malaria. Lancet 348:1196-1201.
15. Pickard, A. L., C. Wongsrichanalai, A. Purfield, D. Kamwendo, K. Emery, C. Zalewski, F. Kawamoto, R. S. Miller, and S. R. Meshnick. 2003. Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1. Antimicrob. Agents Chemother. 47:2418-2423.
16. Plowe, C. V., A. Djimde, M. Bouare, O. Doumbo, and T. E. Wellems. 1995. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am. J. Trop. Med. Hyg. 52:565-568.
17. Reed, M. B., K. J. Saliba, S. R. Caruana, K. Kirk, and A. F. Cowman. 2000. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 403:906-909.
18. Sidhu, A. B., D. Verdier-Pinard, and D. A. Fidock. 2002. Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science 298:210-213.
19. Sisowath, C., J. Stromberg, A. Martensson, M. Msellem, C. Obondo, A. Bjorkman, and J. P. Gil. 2005. In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem). J. Infect. Dis. 191:1014-1017.
20. Staedke, S. G., A. Mpimbaza, M. R. Kamya, B. K. Nzarubara, G. Dorsey, and P. J. Rosenthal. 2004. Combination treatments for uncomplicated falciparum malaria in Kampala, Uganda: randomised clinical trial. Lancet 364:1950-1957.
21. World Health Organization. 2006. Guidelines for the treatment of malaria. World Health Organization, Geneva, Switzerland.
22. Yeka, A., K. Banek, N. Bakyaita, S. G. Staedke, M. R. Kamya, A. Talisuna, F. Kironde, S. L. Nsobya, A. Kilian, M. Slater, A. Reingold, P. J. Rosenthal, F. Wabwire-Mangen, and G. Dorsey. 2005. Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda. PLoS Med. 2:e190.
23. Zongo, I., G. Dorsey, N. Rouamba, H. Tinto, C. Dokomajilar, R. T. Guiguemde, P. J. Rosenthal, and J. B. Ouedraogo. 2007. Artemether- lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial. Lancet 369:491-498. (Erratum, 369:826, 2007.)